Scinai Immunotherapeutics Statistics

Total Valuation

SCNI has a market cap or net worth of $2.25 million. The enterprise value is $2.54 million.

Market Cap	2.25M
Enterprise Value	2.54M

Important Dates

The next estimated earnings date is Tuesday, July 1, 2025, before market open.

Earnings Date	Jul 1, 2025
Ex-Dividend Date	n/a

Share Statistics

SCNI has 933,679 shares outstanding. The number of shares has increased by 106.41% in one year.

Current Share Class	n/a
Shares Outstanding	933,679
Shares Change (YoY)	+106.41%
Shares Change (QoQ)	+46.50%
Owned by Insiders (%)	17.35%
Owned by Institutions (%)	14.27%
Float	668,426

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.98
Forward PS	n/a
PB Ratio	0.64
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.21.

Current Ratio	1.32
Quick Ratio	1.21
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.07

Financial Efficiency

Return on equity (ROE) is 177.37% and return on invested capital (ROIC) is -38.49%.

Return on Equity (ROE)	177.37%
Return on Assets (ROA)	-34.92%
Return on Invested Capital (ROIC)	-38.49%
Return on Capital Employed (ROCE)	-74.20%
Revenue Per Employee	$21,226
Profits Per Employee	n/a
Employee Count	31
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.60% in the last 52 weeks. The beta is 2.09, so SCNI's price volatility has been higher than the market average.

Beta (5Y)	2.09
52-Week Price Change	-32.60%
50-Day Moving Average	2.59
200-Day Moving Average	3.27
Relative Strength Index (RSI)	44.77
Average Volume (20 Days)	1,051,200

Short Selling Information

Short Interest	430
Short Previous Month	4,954
Short % of Shares Out	0.05%
Short % of Float	0.06%
Short Ratio (days to cover)	0.03

Income Statement

Revenue	658,000
Gross Profit	-580,000
Operating Income	-8.64M
Pretax Income	-19.70M
Net Income	n/a
EBITDA	-6.99M
EBIT	-8.64M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $1.96 million in cash and $2.09 million in debt, giving a net cash position of -$122,000 or -$0.13 per share.

Cash & Cash Equivalents	1.96M
Total Debt	2.09M
Net Cash	-122,000
Net Cash Per Share	-$0.13
Equity (Book Value)	9.98M
Book Value Per Share	5.10
Working Capital	585,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.34 million and capital expenditures -$12,000, giving a free cash flow of -$6.35 million.

Operating Cash Flow	-6.34M
Capital Expenditures	-12,000
Free Cash Flow	-6.35M
FCF Per Share	-$6.80

Full Cash Flow Statement

Margins

Gross margin is -88.15%, with operating and profit margins of -1,312.77% and 728.88%.

Gross Margin	-88.15%
Operating Margin	-1,312.77%
Pretax Margin	728.88%
Profit Margin	728.88%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCNI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-106.41%
Shareholder Yield	-106.41%
Earnings Yield	n/a
FCF Yield	-262.46%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 21, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	May 21, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

SCNI has an Altman Z-Score of -13.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.81
Piotroski F-Score	1